Fresenius SE Total Non-Operating Income/Expense 2016-2024 | FSNUY

Fresenius SE annual/quarterly total non-operating income/expense history and growth rate from 2016 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
  • Fresenius SE total non-operating income/expense for the quarter ending June 30, 2024 was $-0.115B, a 42.57% decline year-over-year.
  • Fresenius SE total non-operating income/expense for the twelve months ending June 30, 2024 was $-0.353B, a 46.67% decline year-over-year.
  • Fresenius SE annual total non-operating income/expense for 2023 was $-0.463B, a 13.28% decline from 2022.
  • Fresenius SE annual total non-operating income/expense for 2022 was $-0.534B, a 10.77% decline from 2021.
  • Fresenius SE annual total non-operating income/expense for 2021 was $-0.599B, a 20.47% decline from 2020.
Fresenius SE Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $-463
2022 $-534
2021 $-599
2020 $-753
2019 $-805
2018 $-693
2017 $-736
2016 $-644
2015 $-681
Fresenius SE Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-06-30 $-115
2024-03-31 $-157
2023-12-31 $29
2023-09-30 $-109
2023-06-30 $-201
2023-03-31 $-182
2022-12-31 $-136
2022-09-30 $-142
2022-06-30 $-123
2022-03-31 $-132
2021-12-31 $-139
2021-09-30 $-149
2021-06-30 $-146
2021-03-31 $-165
2020-12-31 $-188
2020-09-30 $-180
2020-06-30 $-184
2020-03-31 $-201
2019-12-31 $-204
2019-09-30 $-191
2019-06-30 $-201
2019-03-31 $-209
2018-12-31 $-158
2018-09-30 $-167
2018-06-30 $-185
2018-03-31 $-183
2017-12-31 $-188
2017-09-30 $-192
2017-06-30 $-189
2017-03-31 $-167
2016-12-31 $-162
2016-09-30 $-157
2016-06-30 $-157
2016-03-31 $-168
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.704B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00